121 related articles for article (PubMed ID: 31663661)
1. Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas.
Fortin Ensign S; Bollin K; Millis SZ; Hinds BR; Kosty M; Uchiyama C
Pigment Cell Melanoma Res; 2020 May; 33(3):458-465. PubMed ID: 31663661
[TBL] [Abstract][Full Text] [Related]
2. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
Küsters-Vandevelde HV; van Engen-van Grunsven IA; Coupland SE; Lake SL; Rijntjes J; Pfundt R; Küsters B; Wesseling P; Blokx WA; Groenen PJ
Pathol Oncol Res; 2015 Apr; 21(2):439-47. PubMed ID: 25315378
[TBL] [Abstract][Full Text] [Related]
3. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
[TBL] [Abstract][Full Text] [Related]
4. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
[TBL] [Abstract][Full Text] [Related]
5. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
6. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
[TBL] [Abstract][Full Text] [Related]
7. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
[TBL] [Abstract][Full Text] [Related]
8. Primary leptomeningeal melanoma: the prognostic significance of its genetic signature and embryological origin.
Buckland A; Green C; Kho LK; Prentice D
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031065
[TBL] [Abstract][Full Text] [Related]
9. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
[TBL] [Abstract][Full Text] [Related]
10. GNAQ
Urtatiz O; Cook C; Huang JL; Yeh I; Van Raamsdonk CD
Pigment Cell Melanoma Res; 2020 Jan; 33(1):96-111. PubMed ID: 31680437
[TBL] [Abstract][Full Text] [Related]
11. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
12. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.
Küsters-Vandevelde HV; Klaasen A; Küsters B; Groenen PJ; van Engen-van Grunsven IA; van Dijk MR; Reifenberger G; Wesseling P; Blokx WA
Acta Neuropathol; 2010 Mar; 119(3):317-23. PubMed ID: 19936769
[TBL] [Abstract][Full Text] [Related]
13. Uveal Melanoma:
Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
[TBL] [Abstract][Full Text] [Related]
14. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study.
Taskin OC; Sari SO; Yilmaz I; Hurdogan O; Keskin M; Buyukbabani N; Gulluoglu M
Turk Patoloji Derg; 2023; 39(1):23-30. PubMed ID: 35642348
[TBL] [Abstract][Full Text] [Related]
15. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA
Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128
[TBL] [Abstract][Full Text] [Related]
16. GNAQ mutation in a patient with metastatic mucosal melanoma.
Kim CY; Kim DW; Kim K; Curry J; Torres-Cabala C; Patel S
BMC Cancer; 2014 Jul; 14():516. PubMed ID: 25030020
[TBL] [Abstract][Full Text] [Related]
17. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
[TBL] [Abstract][Full Text] [Related]
18. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
[TBL] [Abstract][Full Text] [Related]
19. Low mutational burden of eight genes involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways in female genital tract primary melanomas.
Pappa KI; Vlachos GD; Roubelakis M; Vlachos DE; Kalafati TG; Loutradis D; Anagnou NP
Biomed Res Int; 2015; 2015():303791. PubMed ID: 25695059
[TBL] [Abstract][Full Text] [Related]
20. Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis.
Küsters-Vandevelde HV; Kruse V; Van Maerken T; Boterberg T; Pfundt R; Creytens D; Van den Broecke C; Machielsen TC; Koelsche C; von Deimling A; Küsters B; Groenen PJ; Wesseling P; Blokx WA
Exp Mol Pathol; 2017 Feb; 102(1):25-31. PubMed ID: 27974237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
